5. A Method of treating an HBV infected host comprising the
administration of an effective HBV treatment amount of the
compound
NMI
wherein R is hydrogen or C,-, alkyl or a pharmaceutically
acceptable salt thereof to said HBV infected host.
9. In our decision on preliminary motions (Paper 65), we provisionally granted Belleau's
preliminary motion to add count 2 (preliminary motion 1) and Belleau's preliminary
motion to add count 3 (preliminary motion 16) to the interference (Paper 65 at 20).
10. Count 2 reads as follows:
A method of treating hepatitis B virus infection and/or inhibiting
hepatitis B virus replication in a patient in need thereof, including
humans and other mammals, comprising administering to said
patient an effective amount of (-)-cis-4-amino- 1 -(2
hydroxymethyl- 1,3-oxathiolan-5-yl)-(l H)-pyrimidin-2-one of the
formula:
7
Page: Previous 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 Next
Last modified: November 3, 2007